CNBC: “given biotech’s part in growing areas of “concierge medicine” — and DNA-based medicine. And along with the aging U.S. population, Wolff said, he believes biotech names can thrive.”
LEARN MORE ABOUT “Genetic Concierge Medicine” …
Beaten-up biotech stocks could fall further, according to one technical analyst who sees trouble in the charts. A handful of biotech names like Celgene, Amgen and Biogen fell Wednesday after remarks by President-elect Donald Trump in an interview with Time magazine were released.
WATCH VIDEO … | READ FULL STORY …